[1] |
Montero PH, Patel SG.Cancer of the oral cavity[J].Surg Oncol Clin NAm, 2015, 24(3):491-508
|
[2] |
Le Campion A, Ribeiro CMB, Luiz RR, et al.Low survival rates of oral and oropharyngeal squamous cell carcinoma[J].Int J Dent, 2017, 2017:5815493-
|
[3] |
de Martel C, Franceschi S.Infections and cancer: established associations and new hypotheses[J].Crit Rev Oncol Hematol, 2009, 70(3):183-194
|
[4] |
Gethings-Behncke C, Coleman HG, Jordao HWT, et al.Fusobacterium nucleatum in the colorectum,and its association with cancer risk and survival: a systematic review and meta-analysis[J].Cancer Epidemiol Biomarkers Prev, 2020, 29(3):539-548
|
[5] |
Laplagne C, Domagala M, Le Naour A, et al.Latest Advances in Targeting the Tumor Microenvironment for Tumor SuppressionInt J Mol Sci,2019,20(19).[J].Int J Mol Sci, 2019, 20(19):-
|
[6] |
Alves AM, Diel LF, Lamers ML.Macrophages and prognosis of oral squamous carcinoma: A systematic review[J].J Oral Pathol Med, 2018, 47(5):460-467
|
[7] |
Zhou Z, Chen J, Yao H, et al.Fusobacterium?and?Colorectal Cancer[J].Front Oncol, 2018, 8:371-
|
[8] |
Sahingur SE, Xia XJ, Schifferle RE.Oral Bacterial DNA Differ in Their Ability to Induce Inflammatory Responses in Human Monocytic Cell Lines[J].J PeriodontoL, 2012, 83(8):1069-1077
|
[9] |
Du F, Guo T, Cao C.Restoration of UPK1A-AS1 Expression Suppresses Cell Proliferation,Migration,and Invasion in Esophageal Squamous Cell Carcinoma Cells Partially by Sponging microRNA-1248[J].Cancer Manag Res, 2020, 12:2653-2662
|
[10] |
Wu J, Li Q, Fu X.Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity[J].Transl Oncol, 2019, 12(6):846-851
|
[11] |
Feng QY, Chang WJ, Mao YH, et al.Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients With Stage II Colon Cancer[J].Clin Cancer Res, 2019, 25(13):3896-3907
|
[12] |
Xiao M, Zhang JJ, Chen WJ, et al.M1-like Tumor-Associated Macrophages Activated by Exosome-Transferred THBS1 Promote Malignant Migration in Oral Squamous Cell Carcinoma[J].J Exp Clin Cancer Res, 2018, 37(1):143-
|
[13] |
Van Furth R, Raeburn JA, van Zwet TL.Characteristics of Human Mon onuclear Phagocytes[J].Blood, 1979, 54(2):485-500
|
[14] |
Andrea L, Ho T, Jun Y.Fusobacterium and Escherichia: Models of Colorectal Cancer Driven by Microbiota and the Utility of Microbiota in Colorectal Cancer Screening[J].Expert Rev Gastroenterol Hepatol, 2015, 9(5):651-657
|
[15] |
Nagashima H, Ishii N, So T.Regulation of Interleukin-6 Receptor Signaling by TNF Receptor-Associated Factor 2 and 5 During Differentiation of Inflammatory CD4+ T Cells[J].Front Immunol, 2018, 9:1986-
|
[16] |
Polak KL, Chernosky NM, Smigiel JM, et al.Balancing STAT Activity as a Therapeutic StrategyCancers (Basel),2019,11(11).[J].Biomed Pharmacother, 2018, 108:618-624
|
[17] |
Gao SK, Hu JW, Wu XW, et al.PMA Treated THP-1-derived-IL-6 Promotes EMT of SW48 Through STAT3ERK-dependent Activation of Wntβ-catenin Signaling Pathway[J].Biomed Pharmacother, 2018, 108:618-624
|
[18] |
Hou LM, Xie SL, Li GW, et al.IL-6 Triggers the Migration and Invasion of Oestrogen Receptor-Negative Breast Cancer Cells via Regulation of Hippo Pathways[J].Basic Clin Pharmacol Toxicol, 2018, 123(5):549-557
|
[19] |
Vinocha A, Grover RK, Deepak R.Clinical significance of interleukin-6 in diagnosis of lung,oral,esophageal,and gall bladder carcinomas[J].J Cance r Res Ther, 2018, 14(Supplement):S758-S760
|
[20] |
Ma K, Zhang H.Baloch ZPathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systema tic Review[J].Int J Mol Sci, 2016, 17:733-
|
[21] |
Turner NA, Mughal RS, Warburton P, et al.Mechanism of TNFalpha-induced IL-1alpha,IL-1beta and IL-6 expression in human cardiacfibroblasts: effects of statins and thiazolidinediones[J].Cardiovasc Res, 2007, 76(1):81-90
|
[22] |
Wu Y, Zhou BP.TNF-alphaNF-kappaBSnail pathway in cancer cell migration and invasion[J].Br J Cancer, 2010, 102(4):639-644
|
[23] |
Szlosarek P, Charles KA, Balkwill FR.Tumour necrosis factor-alpha as a tumour promoter[J].Eur J Cancer, 2006, 42:745-750
|
[24] |
Chen J, Li N, Liu B, et al.Pracinostat (SB939),a histone deacetylase inhibitor,suppresses breast cancermetastasis and growth by inactivating the IL-6STAT3 signalling pathways[J].Life Sci, 2020, 248:117469-
|
[25] |
Tang D, Tao D, Fang Y, et al.TNF-alpha promotes invasion and metastasis via NF-kappa B pathway in oral squamous cell carcinoma[J].Med Sci Monit Basic Res, 2017, 23:141-149
|
[26] |
Li X, Fu Y, Yang B, et al.BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages[J].Front Immunol, 2020, 11:89-
|